Menu
Our organization strives day in and out to embody excellence is everything we do. To achieve this, we get only the best people, put them in the best environments, and regularly upskill everyone in the organization.
Our Credentialing Program is one way we keep our team’s skills and talents at par with the world’s best. It also ensures that our team continues to uphold the quality and competence SGD is known for.
The program is an intensive 30-day program that focuses on upskilling our medical technologists with further training in any of the specialist streams: HEMATOLOGY, IMMUNOCHEMISTRY, OR MICROBIOLOGY.
To push the boundaries of knowledge, foster collaboration, and drive innovation within the organization, we host regular scientific meetings for team members across the country.
Beyond strengthening the team’s relationship, these gatherings cultivate forward thinkers by keeping the people in our organization up to speed on best practices and the latest innovations in the scientific community.
This future think initiative is designed to build and foster the company’s next gen leadership. Built on a curriculum designed by the company’s leadership, the program is an intensive three-month long annual event managed entirely by the Executive Team. It aims to identify and develop individuals capable of becoming pivotal front runners in the future.
The participants chosen for the program are highly talented and dedicated team members with the ability to not only take the Group far into tomorrow, but to serve their communities, organizations, and the country as well.
Group Chief Executive Officer, Pathology Asia Holdings
Bharath brings over 28 years of leadership experience from across the telecommunications, retail, FMCG, and healthcare industries. Since joining Pathology Asia in 2024, he has driven strategic growth and operational excellence within Southeast Asia’s largest laboratory network.
Previously, Bharath served as CEO of Dr. Lal PathLabs and held key leadership roles at Bharti Airtel, Bharti-Walmart, Unilever, and Wipro Infotech, consistently delivering innovation and market expansion. His expertise continues to strengthen Pathology Asia’s position in the regional healthcare sector.
– Vice Chairman (Group) Pathology Asia Holdings
– Executive Director
Pathology Asia (Australia)
Dr. Chris, co-founder of Pathology Asia and Biomark Labs, is a seasoned leader in pathology and biomedical sciences. He has served as CEO of Innovative Diagnostics, Quantum Diagnostics, Quest Laboratories, and Gribbles Pathology.
Chris held a key role at the Economic Development Board of Singapore’s Biomedical Sciences Group. Clinically trained, he fluidly combines medical expertise and business acumen to drive Pathology Asia’s growth and innovation.
– President & CEO
Singapore Diagnostics
– Regional Director
Pathology Asia Holdings
Ritche helms Singapore Diagnostics, growing it into one of the largest medical laboratories in the Philippines. He co-founded Biomark (Singapore) and previously expanded MyHealth Clinic into a leading medical center chain.
With an MBA from Australia’s famed Southern Cross University, his career spans leadership roles at several large conglomerates, including the healthcare, IT, and finance conglomerate, Equicom Group; and the Philippine financial powerhouse, the Yuchengco Group of Companies.
Chief Operating Officer, Singapore Diagnostics
Norely is a seasoned healthcare professional with over 30 years of expertise in laboratory operations, business development, and people management. Known for driving operational excellence and innovation, she played a key role in Singapore Diagnostics’s significant response during
the COVID-19 pandemic.
She began her career at the National Kidney and Transplant Institute (NKTI) and holds a postgraduate certification from the National University of Singapore.
Chief Pathologist,
Singapore Diagnostics
Doc Paulo serves as Chief Pathologist at Singapore Diagnostics and is affiliated with leading Philippine hospitals, including the National Kidney and Transplant Institute (NKTI), Cardinal Santos Medical Center, Makati Medical Center, and Asian Hospital and Medical Center.
He earned his medical degree from the University of Sto. Tomas and completed his residency at NKTI. Board-certified in Anatomic and Clinical Pathology by the Philippine Society of Pathologists, he has also pursued subspecialty training in Breast and Liver Pathology at the Singapore General Hospital, Prince of Wales Hospital (Hong Kong), and the Beth Israel Deaconess Medical Center in Boston, Massachusetts.
Copyright 2025 Singapore Diagnostics. All Rights Reserved.
